Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABCA2,ATP-binding cassette sub-family A member 2,16789,1204,1.32 [1.15-1.53],0.0001311438425593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",19413,1415,1.18 [1.11-1.24],1.815000371447473e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAN,Aggrecan core protein,19682,1438,0.72 [0.60-0.85],0.0001285909285734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE2,Angiotensin-converting enzyme 2,19484,1436,1.33 [1.23-1.44],5.959563690311568e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,19977,1460,1.30 [1.13-1.49],0.0002824204664998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,19653,1442,1.83 [1.56-2.15],2.015112239537968e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY1,Aminoacylase-1,19876,1453,1.31 [1.22-1.40],2.698490800879096e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA2,Adenosine deaminase 2,19758,1441,1.20 [1.08-1.33],0.0008484552982172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,16871,1216,1.68 [1.40-2.01],3.1795016623627875e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,19686,1445,0.73 [0.64-0.82],8.37359972944651e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,16871,1216,1.35 [1.16-1.56],8.505710187320232e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,19953,1462,0.83 [0.75-0.92],0.0002478961042593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,17385,1242,1.79 [1.53-2.10],6.256764824653947e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,17016,1209,1.48 [1.30-1.68],3.132501505459073e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,19775,1444,1.13 [1.07-1.19],3.272759440250256e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG2,Adhesion G-protein coupled receptor G2,19876,1453,0.72 [0.60-0.85],0.0001319437579512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADM,Pro-adrenomedullin,20020,1460,2.24 [1.87-2.67],6.454596065803272e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGER,Advanced glycosylation end product-specific receptor,19841,1449,0.80 [0.71-0.89],6.415340428506575e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR2,Anterior gradient protein 2 homolog,19273,1421,1.13 [1.08-1.19],1.7460079828109018e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRN,Agrin,19957,1459,1.43 [1.27-1.62],5.166726329862201e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGXT,Serine--pyruvate aminotransferase,19876,1453,1.18 [1.11-1.25],6.523935366977537e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",19788,1453,1.22 [1.16-1.30],2.33252127503178e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",17344,1237,1.33 [1.18-1.50],5.296170473137948e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPP,"Alkaline phosphatase, placental type",19775,1444,1.27 [1.22-1.32],1.9100991241155323e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBP,Protein AMBP,19987,1459,1.60 [1.28-1.99],2.690385648738042e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMOT,Angiomotin,17016,1209,0.71 [0.61-0.82],4.963455767821738e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANG,Angiogenin,19833,1446,1.31 [1.15-1.50],7.258939072211381e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT2,Angiopoietin-2,20020,1460,1.71 [1.52-1.91],1.7955859165340078e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,19922,1455,1.41 [1.27-1.56],7.001069646866451e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,20020,1460,1.33 [1.17-1.50],7.219932287485743e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA10,Annexin A10,19427,1432,1.09 [1.04-1.15],0.0006318676511609
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APLP1,Amyloid-like protein 1,19876,1453,0.82 [0.75-0.90],1.7952524531339916e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA2,Apolipoprotein A-II,17396,1246,1.25 [1.12-1.39],4.59324000050938e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AREG,Amphiregulin,19775,1444,1.72 [1.56-1.89],3.271564976314852e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,19686,1445,1.87 [1.64-2.14],3.763847736819176e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,17396,1246,1.84 [1.51-2.25],1.9785537755258783e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AZU1,Azurocidin,19263,1417,1.10 [1.04-1.17],0.0005536362776865
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B2M,Beta-2-microglobulin,17415,1251,1.45 [1.23-1.71],1.1632137640833028e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",19957,1459,1.36 [1.15-1.60],0.0002459417948892
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,19413,1415,1.17 [1.09-1.26],1.6201596231491136e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAN,Brevican core protein,19686,1445,0.64 [0.56-0.73],3.6419566661127966e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,16871,1216,1.26 [1.11-1.43],0.0002292018033828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB1,BPI fold-containing family B member 1,19819,1451,1.29 [1.20-1.39],1.7793942685465582e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSG,Basigin,20026,1466,1.64 [1.32-2.03],7.395143993921127e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST2,Bone marrow stromal antigen 2,20026,1465,1.42 [1.32-1.52],6.564257785390899e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,19827,1454,1.29 [1.16-1.44],2.5904718605820976e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C19orf12,Protein C19orf12,19427,1432,1.13 [1.06-1.20],0.0003887816123696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C5,Complement C5,17415,1251,1.90 [1.33-2.73],0.0004593573131765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7,Complement component C7,16970,1225,1.49 [1.25-1.78],7.060933384251028e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA4,Carbonic anhydrase 4,20111,1473,1.46 [1.21-1.77],9.978344825981034e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",19484,1436,1.13 [1.08-1.19],1.1794482493209513e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA6,Carbonic anhydrase 6,19835,1455,0.85 [0.79-0.91],1.3724796942656882e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCA,Calcitonin,19654,1442,1.14 [1.06-1.22],0.0001858350985113
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPG,Macrophage-capping protein,19686,1436,1.25 [1.16-1.35],2.065218191115209e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP1,Caspase-1,19427,1432,1.15 [1.08-1.23],7.574731867642817e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN4,Cerebellin-4,20020,1460,0.68 [0.59-0.79],2.119104498810744e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBS,Cystathionine beta-synthase,16956,1214,1.24 [1.12-1.38],3.239614297632753e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,19876,1453,1.36 [1.21-1.53],2.6368867818864506e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL14,C-C motif chemokine 14,19833,1446,1.21 [1.08-1.35],0.0006069664325759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL15,C-C motif chemokine 15,20111,1473,1.32 [1.20-1.46],3.4266878616024854e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL16,C-C motif chemokine 16,20111,1473,1.25 [1.14-1.37],2.0624452350226685e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL17,C-C motif chemokine 17,19837,1448,1.13 [1.07-1.18],2.1089587665319072e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL18,C-C motif chemokine 18,19601,1433,1.11 [1.05-1.18],0.0007534081995025
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL20,C-C motif chemokine 20,20057,1466,1.20 [1.15-1.25],6.497649946179091e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL21,C-C motif chemokine 21,19957,1459,1.29 [1.17-1.41],1.8750440780521562e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL22,C-C motif chemokine 22,19705,1436,1.25 [1.15-1.36],9.371907205380409e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL23,C-C motif chemokine 23,19957,1459,1.32 [1.19-1.48],5.104756879424369e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL25,C-C motif chemokine 25,20057,1466,1.20 [1.09-1.32],0.0002077105604066
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL27,C-C motif chemokine 27,19876,1453,1.18 [1.09-1.28],2.7172704508639394e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL28,C-C motif chemokine 28,19761,1447,1.17 [1.09-1.26],1.470397671868361e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL3,C-C motif chemokine 3,19827,1454,1.25 [1.18-1.32],5.4271154375387305e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL7,C-C motif chemokine 7,19827,1454,1.29 [1.21-1.38],6.726225319226836e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN1,CCN family member 1,19735,1442,1.13 [1.06-1.20],0.0002861095944106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD14,Monocyte differentiation antigen CD14,19508,1426,1.48 [1.33-1.65],2.1006609482286628e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD248,Endosialin,17385,1242,0.70 [0.61-0.80],3.6058752416918985e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD27,CD27 antigen,19953,1462,1.38 [1.25-1.53],4.3957669773643455e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD274,Programmed cell death 1 ligand 1,19686,1445,1.49 [1.32-1.68],1.3812305506289162e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300C,CMRF35-like molecule 6,20026,1465,1.32 [1.17-1.50],1.5742962278355963e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300E,CMRF35-like molecule 2,19954,1456,1.36 [1.23-1.51],7.062592917798492e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD302,CD302 antigen,19775,1444,1.63 [1.43-1.86],2.0582425440725521e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD34,Hematopoietic progenitor cell antigen CD34,19968,1461,0.61 [0.51-0.75],8.326397214406069e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD4,T-cell surface glycoprotein CD4,19800,1448,1.45 [1.30-1.62],3.0337655850257425e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,19862,1451,1.18 [1.08-1.30],0.0003581812246922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5,T-cell surface glycoprotein CD5,19987,1459,1.36 [1.22-1.53],4.881603490890116e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD59,CD59 glycoprotein,19177,1389,1.41 [1.17-1.69],0.0002906056363877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,20026,1465,1.37 [1.21-1.56],1.1624782478867237e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD80,T-lymphocyte activation antigen CD80,17380,1244,1.33 [1.13-1.57],0.0005298176979323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD83,CD83 antigen,19827,1454,1.51 [1.34-1.70],3.5226946175814117e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99L2,CD99 antigen-like protein 2,19888,1463,1.68 [1.40-2.02],3.5392858912065105e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDCP1,CUB domain-containing protein 1,19686,1445,1.44 [1.33-1.55],8.237499593079806e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH2,Cadherin-2,19876,1453,1.28 [1.12-1.46],0.0002390034752342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH5,Cadherin-5,20111,1473,0.73 [0.62-0.85],6.354846304407069e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR2,Cadherin-related family member 2,19775,1444,1.13 [1.05-1.21],0.0008350050908492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR5,Cadherin-related family member 5,19876,1453,0.82 [0.73-0.92],0.0007058487417928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,19921,1460,1.82 [1.45-2.27],1.5904758522344722e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,17296,1239,0.76 [0.71-0.81],2.7329292185462567e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,19185,1394,1.39 [1.30-1.49],1.5417573431336288e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,17385,1242,1.67 [1.51-1.84],4.6547080742333414e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,19484,1436,1.30 [1.19-1.41],4.562652211501124e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES1,Liver carboxylesterase 1,19938,1460,1.13 [1.08-1.19],2.9952494247629262e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFB,Complement factor B,17108,1230,1.53 [1.28-1.84],4.807584249274742e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFD,Complement factor D,17415,1251,1.53 [1.19-1.96],0.0007949890245893
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFI,Complement factor I,17415,1251,1.77 [1.33-2.37],0.0001101656346591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGA,Glycoprotein hormones alpha chain,19888,1463,1.13 [1.05-1.21],0.0009300272524614
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,19876,1453,1.20 [1.08-1.33],0.0006732055985163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHAD,Chondroadherin,17016,1209,0.76 [0.68-0.84],2.2832247616530505e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",17349,1240,1.56 [1.40-1.75],1.1188728080500601e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD6,MICOS complex subunit MIC25,17296,1230,1.84 [1.61-2.09],5.102669682889929e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGA,Chromogranin-A,17385,1242,1.19 [1.13-1.25],5.2551382199753386e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHI3L1,Chitinase-3-like protein 1,19465,1418,1.36 [1.30-1.43],1.2867327078947323e-35
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CILP,Cartilage intermediate layer protein 1,17385,1242,1.28 [1.15-1.43],4.173235525250928e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,19967,1462,1.63 [1.41-1.88],3.2155112875259094e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKB,Creatine kinase B-type,17385,1242,1.21 [1.11-1.33],4.215192992949143e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,19686,1445,1.26 [1.10-1.43],0.0006330312151016
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC3B,Tetranectin,17004,1221,0.47 [0.37-0.61],9.166713069411612e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,19827,1454,1.34 [1.25-1.44],1.0136699034046665e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,19818,1450,1.63 [1.41-1.88],4.3702898267670005e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,19413,1415,1.25 [1.13-1.38],1.4332348721417803e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLMP,CXADR-like membrane protein,20020,1460,1.61 [1.32-1.98],4.009734889459651e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN2,Calsyntenin-2,20057,1466,1.21 [1.09-1.35],0.0004970883056641
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLUL1,Clusterin-like protein 1,19844,1453,0.83 [0.75-0.92],0.0003222412998971
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN1,Contactin-1,20111,1473,0.62 [0.52-0.73],1.0843950462257648e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN5,Contactin-5,19899,1453,0.76 [0.67-0.86],2.09488147682542e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,19969,1462,2.07 [1.72-2.49],2.6837268572896376e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL1A1,Collagen alpha-1(I) chain,20111,1473,0.69 [0.57-0.83],0.0001119364319499
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,19876,1453,1.22 [1.09-1.37],0.0007966184433333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,20111,1473,1.44 [1.28-1.62],5.481044078090716e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COLEC12,Collectin-12,19870,1451,1.48 [1.26-1.74],2.369405418398755e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA1,Carboxypeptidase A1,20111,1473,1.14 [1.06-1.22],0.0003853435664609
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPM,Carboxypeptidase M,19921,1456,1.29 [1.13-1.48],0.0001584791335932
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CR2,Complement receptor type 2,19969,1459,0.84 [0.76-0.93],0.0005395166654547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREG1,Protein CREG1,19635,1444,1.34 [1.20-1.50],1.3930961411939885e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,19870,1451,1.38 [1.17-1.63],0.0001716138450059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP2,Cysteine-rich secretory protein 2,20020,1460,0.88 [0.81-0.95],0.0008316523523927
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP3,Cysteine-rich secretory protein 3,17247,1236,0.71 [0.58-0.87],0.0009739894680773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,19957,1459,1.38 [1.17-1.62],0.0001430938078783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSPG4,Chondroitin sulfate proteoglycan 4,17385,1242,0.69 [0.59-0.81],5.779632457826519e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST3,Cystatin-C,19937,1457,1.50 [1.29-1.73],6.536164670337576e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST7,Cystatin-F,19897,1455,1.09 [1.04-1.13],0.0001187286565708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSTB,Cystatin-B,19591,1437,1.40 [1.26-1.56],2.8462734765094707e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,17349,1240,0.86 [0.80-0.92],6.557676937863643e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSC,Dipeptidyl peptidase 1,19828,1449,1.25 [1.13-1.39],1.4094171517801145e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSD,Cathepsin D,18628,1359,1.71 [1.57-1.85],2.799365714811981e-37
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSF,Cathepsin F,19953,1462,1.28 [1.14-1.43],2.443946402541175e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSL,Cathepsin L1,19876,1453,1.56 [1.30-1.87],2.088282353557755e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSO,Cathepsin O,20057,1466,1.28 [1.11-1.48],0.0007186663892917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSZ,Cathepsin Z,19914,1456,1.27 [1.11-1.47],0.0007968266285412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,19827,1454,1.39 [1.28-1.52],1.768679498447e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL10,C-X-C motif chemokine 10,19957,1459,1.13 [1.05-1.20],0.0006670060210512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL13,C-X-C motif chemokine 13,20026,1465,1.11 [1.05-1.18],0.000771539503863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL16,C-X-C motif chemokine 16,20084,1473,1.65 [1.36-1.99],2.447895039691324e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL17,C-X-C motif chemokine 17,20057,1466,2.34 [2.13-2.58],4.244395443407167e-66
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL8,Interleukin-8,19717,1432,1.13 [1.07-1.21],7.897506625393242e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL9,C-X-C motif chemokine 9,19957,1459,1.24 [1.16-1.32],2.425775777609376e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYB5R2,NADH-cytochrome b5 reductase 2,17115,1229,1.17 [1.07-1.28],0.000428877680849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",19775,1444,1.34 [1.21-1.48],9.009712707189108e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,20026,1465,1.49 [1.22-1.81],7.995677758224534e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,16956,1214,0.79 [0.72-0.86],1.1080487620091365e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPEP1,Dipeptidase 1,19654,1442,0.85 [0.77-0.93],0.0005146267526279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,19827,1454,1.54 [1.38-1.74],2.3705247226599137e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,19775,1444,0.78 [0.68-0.89],0.000298805679426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP7,Dipeptidyl peptidase 2,19731,1441,1.33 [1.23-1.43],9.16545517714064e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPY30,Protein dpy-30 homolog,19949,1454,1.17 [1.08-1.26],5.866130350836978e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTNB,Dystrobrevin beta,17258,1229,1.36 [1.20-1.53],1.3084004424684e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,19775,1444,1.36 [1.14-1.62],0.0006926001250974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",17380,1244,1.27 [1.18-1.36],1.197913084275725e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHS1,"Enoyl-CoA hydratase, mitochondrial",16956,1214,1.12 [1.06-1.19],7.081397151312171e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,20020,1460,1.36 [1.21-1.52],9.053206710588434e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,19484,1436,1.40 [1.22-1.60],1.8588009872746125e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDN1,Endothelin-1,16956,1214,1.75 [1.47-2.09],7.152399243000725e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EEF1D,Elongation factor 1-delta,17380,1244,1.10 [1.04-1.17],0.0009967325663773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA1,Ephrin-A1,19858,1460,1.72 [1.50-1.98],4.3635503411283096e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA4,Ephrin-A4,19653,1442,1.58 [1.39-1.79],4.437713388943759e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,19413,1415,1.30 [1.16-1.46],8.085992800412095e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFLAM,Pikachurin,17296,1239,1.40 [1.18-1.66],0.0001439413375644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFR,Epidermal growth factor receptor,20111,1473,0.51 [0.39-0.67],2.0977088671771293e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGLN1,Egl nine homolog 1,19827,1454,1.26 [1.18-1.34],3.26080142484782e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,19876,1453,1.15 [1.07-1.23],5.358491640507113e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELOA,Elongin-A,19775,1444,1.16 [1.08-1.25],7.552206268441041e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENDOU,Poly(U)-specific endoribonuclease,16034,1150,0.81 [0.73-0.91],0.0002173512420664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPEP,Glutamyl aminopeptidase,16789,1204,1.20 [1.09-1.33],0.0002962695408575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,19957,1459,0.78 [0.71-0.86],2.830854257690477e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,19210,1401,1.19 [1.12-1.26],3.519992952703185e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA2,Ephrin type-A receptor 2,19157,1388,1.31 [1.14-1.51],0.0001415883870172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA4,Ephrin type-A receptor 4,17016,1209,0.63 [0.53-0.76],1.6548605490710406e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPO,Erythropoietin,19827,1454,1.16 [1.10-1.23],1.3826474650824616e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,19982,1457,1.38 [1.19-1.61],2.277891483907264e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB2,Receptor tyrosine-protein kinase erbB-2,19953,1462,1.45 [1.19-1.76],0.0001720999727809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EZR,Ezrin,20026,1465,1.56 [1.31-1.86],5.106719902603924e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F9,Coagulation factor IX,19928,1455,1.98 [1.55-2.54],6.213138191763229e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP1,"Fatty acid-binding protein, liver",19870,1451,1.22 [1.17-1.28],7.016123183736273e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",19876,1453,1.13 [1.07-1.20],1.182858339329019e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP3,"Fatty acid-binding protein, heart",17380,1244,1.22 [1.11-1.35],8.290543707358625e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",20111,1473,1.36 [1.25-1.47],6.107644109116725e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM20A,Pseudokinase FAM20A,17380,1244,1.85 [1.60-2.15],2.7281316982852635e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3B,Protein FAM3B,19775,1444,1.36 [1.19-1.56],8.594309617501489e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3C,Protein FAM3C,19839,1450,1.31 [1.13-1.52],0.0002583351789159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAP,Prolyl endopeptidase FAP,20111,1473,0.68 [0.58-0.81],7.917106431468807e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN1,Ficolin-1,17360,1245,1.32 [1.19-1.47],3.440285695427753e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRLB,Fc receptor-like B,19413,1415,1.13 [1.06-1.21],0.0002215486935246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF19,Fibroblast growth factor 19,19957,1459,1.11 [1.04-1.18],0.0006814187616721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF21,Fibroblast growth factor 21,19987,1457,1.26 [1.21-1.31],3.5259704407295246e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF23,Fibroblast growth factor 23,19992,1458,1.35 [1.26-1.44],3.4426691872124237e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,19953,1462,0.73 [0.64-0.84],1.1789087481281872e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,19953,1462,1.77 [1.45-2.17],2.615930947327744e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGL1,Fibrinogen-like protein 1,17396,1246,1.32 [1.22-1.42],1.2367720223162112e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGR,Tyrosine-protein kinase Fgr,19427,1432,1.14 [1.06-1.23],0.0002580149280085
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRZB,Secreted frizzled-related protein 3,19621,1440,0.72 [0.60-0.87],0.000435356590363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FST,Follistatin,19922,1455,1.24 [1.13-1.36],7.65105491537508e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL1,Follistatin-related protein 1,16956,1214,1.62 [1.27-2.07],9.106950459849944e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL3,Follistatin-related protein 3,19834,1447,1.92 [1.69-2.17],3.581518816690059e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FTCD,Formimidoyltransferase-cyclodeaminase,17311,1239,1.11 [1.05-1.18],0.0005616236344155
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUOM,Fucose mutarotase,17016,1209,1.18 [1.08-1.29],0.0003419117325966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FURIN,Furin,19953,1462,1.31 [1.13-1.50],0.0002151726388648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,20026,1465,1.39 [1.26-1.53],6.722223362479102e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAL,Galanin peptides,19957,1459,0.84 [0.79-0.91],4.922263367544109e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,19775,1444,1.58 [1.34-1.87],7.179294708324758e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAST,Gastrin,17349,1240,1.13 [1.09-1.17],5.547099458388049e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP1,Guanylate-binding protein 1,17318,1238,1.19 [1.09-1.29],4.927734318921848e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCG,Pro-glucagon,19413,1415,1.07 [1.03-1.11],0.0005930556165539
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,16614,1186,1.35 [1.23-1.48],7.895955105557949e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF15,Growth/differentiation factor 15,20111,1473,1.94 [1.79-2.10],8.06852675664908e-61
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFER,FAD-linked sulfhydryl oxidase ALR,19413,1415,1.20 [1.11-1.29],1.8510168513243465e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA1,GDNF family receptor alpha-1,19987,1457,1.55 [1.34-1.81],1.1835843964932493e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRAL,GDNF family receptor alpha-like,16826,1205,0.80 [0.72-0.87],1.5101834295296373e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,19858,1460,1.51 [1.39-1.64],4.513676511653651e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,19686,1445,1.50 [1.24-1.83],4.057549220760296e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,17349,1240,1.45 [1.23-1.71],6.229249268790557e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GKN1,Gastrokine-1,19075,1404,1.42 [1.21-1.68],2.820015567604644e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLB1,Beta-galactosidase,19686,1445,1.27 [1.14-1.42],2.4482470928071065e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLO1,Lactoylglutathione lyase,19484,1436,1.18 [1.09-1.27],5.1094809574271454e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLM2,Protein GOLM2,20026,1465,1.37 [1.14-1.65],0.0007277496379706
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPD1,Glycerol-3-phosphate dehydrogenase,17296,1230,1.23 [1.12-1.35],1.988741438630148e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPKOW,G-patch domain and KOW motifs-containing protein,19427,1432,1.46 [1.30-1.65],4.4940944805276145e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR37,Prosaposin receptor GPR37,19484,1436,1.28 [1.19-1.37],4.887048098816462e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,17296,1230,1.30 [1.19-1.41],8.798704580450277e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",19775,1444,1.38 [1.28-1.48],1.1034815429705396e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSN,Gelsolin,17339,1243,0.48 [0.36-0.63],1.245424293822187e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUSB,Beta-glucuronidase,19977,1460,1.16 [1.08-1.25],5.000165672830845e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAO1,Hydroxyacid oxidase 1,20020,1460,1.12 [1.08-1.16],4.5489392059962525e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,19987,1459,1.42 [1.33-1.51],6.881463831294654e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,19888,1463,1.50 [1.33-1.69],5.388253121266204e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGF,Hepatocyte growth factor,20057,1466,1.81 [1.60-2.06],6.685471974329525e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,17309,1238,1.24 [1.11-1.38],0.0001016016663835
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",19827,1454,1.34 [1.15-1.55],0.0001342002840453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX2,Heme oxygenase 2,19427,1432,1.33 [1.22-1.45],4.0099228497988304e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNMT,Histamine N-methyltransferase,19593,1436,1.22 [1.10-1.34],6.671062017826178e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,19413,1415,0.72 [0.63-0.82],5.437372013804592e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPSE,Heparanase,17150,1234,1.10 [1.04-1.17],0.0009665714972521
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,19775,1444,1.23 [1.09-1.38],0.0008023297919111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,19827,1454,1.28 [1.14-1.44],2.4314340188937964e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,19733,1441,1.36 [1.16-1.60],0.000149515103788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYAL1,Hyaluronidase-1,19781,1448,1.62 [1.33-1.97],1.4900306447970384e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM1,Intercellular adhesion molecule 1,19788,1443,1.69 [1.45-1.96],7.611411194255061e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM5,Intercellular adhesion molecule 5,19876,1453,1.39 [1.25-1.54],2.335716986876596e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDUA,Alpha-L-iduronidase,20020,1460,1.19 [1.08-1.31],0.0007073377308353
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,16859,1206,1.71 [1.52-1.92],1.4110831509401666e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR2,Interferon gamma receptor 2,19686,1445,1.23 [1.13-1.34],1.9247031560768644e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,17385,1242,0.55 [0.45-0.66],8.733780345466075e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2R,Cation-independent mannose-6-phosphate receptor,19888,1463,1.68 [1.38-2.05],2.682071555969405e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,20079,1470,1.09 [1.05-1.14],5.970012972723322e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,20088,1470,1.18 [1.09-1.27],2.7268733631076645e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,19629,1445,1.67 [1.54-1.81],7.14256477318073e-36
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,20111,1473,1.62 [1.42-1.83],9.285018414583829e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,19876,1453,1.67 [1.47-1.89],1.061172092622655e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,17380,1247,1.54 [1.25-1.90],4.9306142525217125e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF21,Immunoglobulin superfamily member 21,16956,1214,0.73 [0.63-0.85],5.271794362123944e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,19775,1444,1.27 [1.13-1.43],9.122161812202932e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,19876,1453,1.47 [1.27-1.70],2.534523502900086e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF9,Protein turtle homolog A,17380,1244,1.12 [1.06-1.20],0.0001989613909902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RA,Interleukin-10 receptor subunit alpha,19474,1407,1.15 [1.08-1.24],4.6991835101265264e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,19957,1459,1.44 [1.25-1.67],9.00029499696587e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15,Interleukin-15,19827,1454,1.58 [1.38-1.81],9.087883089306107e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18,Interleukin-18,19809,1448,1.22 [1.10-1.34],0.0001227229354276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18BP,Interleukin-18-binding protein,19969,1459,1.31 [1.14-1.51],0.0001909476861009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18R1,Interleukin-18 receptor 1,20057,1466,1.29 [1.12-1.48],0.000263577967433
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL19,Interleukin-19,19373,1417,1.14 [1.07-1.21],4.292862116494111e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1B,Interleukin-1 beta,19388,1404,1.18 [1.09-1.28],2.487278750762286e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,20051,1469,1.38 [1.24-1.53],1.2537626724618e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,19474,1407,0.70 [0.62-0.80],3.728116014482133e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,19829,1453,1.27 [1.18-1.37],1.4072238618898208e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22,Interleukin-22,17296,1230,1.18 [1.10-1.27],1.3236914871213456e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,19702,1445,1.38 [1.25-1.54],1.994861186835606e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL32,Interleukin-32,19827,1454,1.29 [1.16-1.43],1.1364113337595217e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,19827,1454,1.40 [1.24-1.59],3.685948338519887e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6,Interleukin-6,19775,1444,1.27 [1.21-1.33],1.5762407369229296e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7R,Interleukin-7 receptor subunit alpha,19888,1463,0.83 [0.76-0.90],1.656515785014444e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMMT,MICOS complex subunit MIC60,17296,1230,1.39 [1.25-1.54],3.5214868119100523e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBB,Inhibin beta B chain,17016,1209,1.33 [1.21-1.46],1.596002631703361e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL5,Insulin-like peptide INSL5,17296,1239,1.15 [1.09-1.21],6.905718020466511e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA11,Integrin alpha-11,19827,1454,0.69 [0.60-0.78],2.627214292763505e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAV,Integrin alpha-V,20020,1460,0.48 [0.36-0.63],1.6667949329256697e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,19969,1459,1.31 [1.16-1.48],1.0491248105823768e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,17415,1251,1.51 [1.19-1.92],0.0006978483205978
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JCHAIN,Immunoglobulin J chain,19474,1407,1.15 [1.07-1.24],0.000259275218594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,19775,1444,0.81 [0.74-0.89],1.7023405143637988e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KHK,Ketohexokinase,16956,1214,1.16 [1.06-1.27],0.0009949622132332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KITLG,Kit ligand,19876,1453,0.62 [0.55-0.70],2.2551117321488943e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK11,Kallikrein-11,19764,1442,1.28 [1.13-1.45],0.0001097445601753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK4,Kallikrein-4,20020,1460,1.29 [1.21-1.38],4.1875676679032985e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",19775,1444,1.19 [1.13-1.25],1.6091683053217266e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",19788,1453,1.15 [1.08-1.23],1.383333977673159e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",16791,1203,1.20 [1.15-1.26],2.4422542712519577e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYNU,Kynureninase,20057,1466,1.26 [1.14-1.39],5.314405057119844e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,19870,1451,1.45 [1.30-1.63],6.539417622706766e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,20026,1466,1.48 [1.36-1.61],3.7546693457530403e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAYN,Layilin,19654,1442,1.41 [1.25-1.59],1.8112932121926376e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBR,Delta(14)-sterol reductase LBR,20026,1465,1.15 [1.08-1.22],1.2308176902266322e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LECT2,Leukocyte cell-derived chemotaxin-2,17380,1244,1.15 [1.06-1.26],0.0008577977325212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS1,Galectin-1,19876,1453,1.37 [1.21-1.55],9.511173057704252e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3,Galectin-3,19919,1457,1.31 [1.13-1.53],0.0004222653014366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3BP,Galectin-3-binding protein,17415,1251,1.55 [1.29-1.86],2.7850309187826302e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS4,Galectin-4,19870,1451,1.44 [1.34-1.56],1.627494243572089e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS9,Galectin-9,19862,1451,1.50 [1.30-1.72],2.4870360563038764e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGMN,Legumain,19957,1459,1.53 [1.35-1.73],2.650477180549533e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,19474,1407,1.31 [1.18-1.45],2.748747199391881e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPCAT2,Lysophosphatidylcholine acyltransferase 2,19775,1444,1.24 [1.14-1.35],7.72437521137453e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,17415,1251,1.83 [1.50-2.24],2.775837989489683e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,19474,1407,0.62 [0.55-0.69],9.093333766998855e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTA4H,Leukotriene A-4 hydrolase,20020,1460,1.14 [1.06-1.23],0.0006043536458581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,20111,1473,1.32 [1.14-1.52],0.0001425327470028
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,19782,1445,1.35 [1.16-1.57],0.0001145661480386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY96,Lymphocyte antigen 96,19686,1445,1.24 [1.09-1.41],0.0008927662053428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,19613,1440,1.28 [1.18-1.38],2.146235338946649e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC4,Apical endosomal glycoprotein,17296,1230,1.29 [1.18-1.42],5.252648372147816e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCAM,Cell surface glycoprotein MUC18,19969,1459,0.74 [0.64-0.86],4.330355588611859e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDK,Midkine,19905,1455,1.29 [1.19-1.40],1.4122977009864247e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF9,Multiple epidermal growth factor-like domains protein 9,20051,1469,1.52 [1.20-1.92],0.0004613291241078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1B,Meprin A subunit beta,19876,1453,0.93 [0.90-0.97],0.00034434736214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEPE,Matrix extracellular phosphoglycoprotein,19870,1451,0.57 [0.49-0.67],2.110765097981581e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MET,Hepatocyte growth factor receptor,19918,1458,0.55 [0.44-0.70],7.132106629298733e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFGE8,Lactadherin,19888,1463,1.26 [1.14-1.40],7.733386447330134e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MME,Neprilysin,19775,1444,1.21 [1.15-1.28],1.5293050160952477e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP10,Stromelysin-2,19820,1445,1.22 [1.13-1.31],6.006845345728395e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP12,Macrophage metalloelastase,19862,1448,1.64 [1.52-1.77],1.9301150128880643e-36
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP3,Stromelysin-1,19888,1463,1.19 [1.09-1.31],0.0001064269190917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP7,Matrilysin,19452,1435,1.39 [1.26-1.53],5.3745937495016585e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP8,Neutrophil collagenase,19992,1462,1.15 [1.08-1.23],1.1403732082528956e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP9,Matrix metalloproteinase-9,19852,1462,1.25 [1.15-1.35],2.362624271404215e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MNDA,Myeloid cell nuclear differentiation antigen,19842,1449,1.08 [1.04-1.13],0.0003755549578656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRC1,Macrophage mannose receptor 1,17396,1246,1.42 [1.18-1.70],0.0001874707268465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLN,Mesothelin,19740,1441,1.36 [1.26-1.46],5.1631274247325234e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSMB,Beta-microseminoprotein,19841,1455,1.15 [1.08-1.22],2.581171718455037e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,20026,1465,1.26 [1.14-1.40],5.18841635581303e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSTN,Growth/differentiation factor 8,19484,1436,0.80 [0.73-0.87],4.67655356881086e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTUS1,Microtubule-associated tumor suppressor 1,17058,1223,1.19 [1.09-1.31],0.0002416216040726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC13,Mucin-13,19427,1432,1.17 [1.08-1.28],0.0003216033708154
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MVK,Mevalonate kinase,19474,1407,1.22 [1.16-1.29],1.5609500510332469e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MXRA8,Matrix remodeling-associated protein 8,17016,1209,0.64 [0.53-0.77],1.4904626630214517e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,19932,1456,1.30 [1.20-1.41],4.598790293936943e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,19953,1462,1.40 [1.18-1.65],7.586975720070295e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM1,Neural cell adhesion molecule 1,19969,1459,0.68 [0.59-0.79],9.344660818731194e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAN,Neurocan core protein,20026,1465,0.75 [0.67-0.85],2.718702908807297e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCF2,Neutrophil cytosol factor 2,19802,1451,1.10 [1.05-1.16],0.0002147209367675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN2,Nectin-2,19839,1450,1.57 [1.37-1.81],2.409247509121452e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEFL,Neurofilament light polypeptide,19370,1427,1.33 [1.20-1.46],1.1702287476032121e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,19953,1462,0.73 [0.65-0.81],4.134045814938977e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFASC,Neurofascin,20057,1466,1.36 [1.17-1.59],9.14209391421058e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",19474,1407,1.19 [1.11-1.29],5.528829018923977e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NHLRC3,NHL repeat-containing protein 3,16594,1185,1.53 [1.27-1.83],4.722108194010674e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH1,Neurogenic locus notch homolog protein 1,20111,1473,0.59 [0.44-0.79],0.0004346897385694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,17082,1223,1.67 [1.44-1.93],9.332058761102e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,19876,1453,1.43 [1.27-1.62],1.0521688032260588e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPL,N-acetylneuraminate lyase,17380,1244,1.27 [1.13-1.43],4.247204139563947e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPB,Natriuretic peptides B,19484,1436,1.12 [1.08-1.16],4.924189562024145e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX1,Neuronal pentraxin-1,19888,1463,1.45 [1.30-1.61],3.067456007311961e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,17349,1240,1.60 [1.40-1.84],7.510915876794827e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5E,5'-nucleotidase,19953,1462,1.20 [1.10-1.30],1.4604980509877802e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK3,NT-3 growth factor receptor,20026,1465,0.60 [0.48-0.74],2.399536174444456e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,19876,1453,1.22 [1.18-1.27],2.404408684663889e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUCB2,Nucleobindin-2,19982,1457,1.25 [1.10-1.41],0.0004213233513546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OCLN,Occludin,17344,1237,1.96 [1.74-2.20],1.8126946325325574e-29
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,19681,1440,1.17 [1.09-1.26],2.1838777591823464e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMD,Osteomodulin,19957,1459,0.65 [0.59-0.72],7.536252278539212e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,19775,1444,0.87 [0.81-0.93],6.148145227900302e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,17350,1244,2.01 [1.55-2.60],1.269961728900642e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,19897,1452,1.47 [1.29-1.69],1.5359435146618106e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSM,Oncostatin-M,19740,1448,1.22 [1.14-1.30],4.00228963291692e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,19997,1460,1.60 [1.27-2.02],6.526711566029936e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXT,Oxytocin-neurophysin 1,20026,1465,1.10 [1.07-1.14],4.992248934360031e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,19484,1436,1.17 [1.08-1.27],0.0001125228818055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM2,Paralemmin-2,17349,1240,1.71 [1.49-1.97],1.0950812060534573e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH9,Protocadherin-9,17296,1239,0.76 [0.65-0.89],0.0005823035222436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,20111,1473,1.27 [1.13-1.42],3.381705760412911e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,16871,1216,1.41 [1.24-1.60],9.082167993489156e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGF,Placenta growth factor,20057,1466,1.40 [1.19-1.65],5.990722093883959e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,20028,1466,1.21 [1.09-1.34],0.000215513985633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI3,Elafin,19626,1432,1.16 [1.07-1.26],0.000305972390267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIGR,Polymeric immunoglobulin receptor,19631,1444,2.69 [2.40-3.00],6.8108880964703985e-68
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,19888,1463,1.41 [1.22-1.64],3.6422329070986726e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,19888,1463,1.35 [1.21-1.51],5.469373217251672e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,19876,1453,1.18 [1.09-1.28],7.681885092779372e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G15,Phospholipase A2 group XV,19953,1462,1.88 [1.60-2.21],3.252240036354223e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",19824,1457,1.15 [1.07-1.24],0.0003585480503013
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAT,Tissue-type plasminogen activator,20051,1469,1.33 [1.21-1.45],7.719892299732082e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,19746,1444,3.03 [2.62-3.51],2.280210048925979e-50
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLG,Plasminogen,16987,1225,1.75 [1.39-2.21],2.388839554008763e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLIN3,Perilipin-3,19876,1453,1.21 [1.09-1.34],0.0004705578611741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",19775,1444,1.40 [1.26-1.57],1.213480093577077e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,17344,1237,1.30 [1.16-1.46],7.16427280642225e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAP1,Proline-rich acidic protein 1,17385,1242,1.54 [1.34-1.77],1.3215189427375843e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,20009,1459,1.34 [1.15-1.55],0.0001014681525383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS2,Trypsin-2,19969,1459,1.29 [1.20-1.39],1.4433104761365718e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS8,Prostasin,19793,1452,1.87 [1.69-2.08],1.4725906827906656e-32
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAP,Prosaposin,17213,1238,1.51 [1.25-1.83],2.349193191796093e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGR1,Prostaglandin reductase 1,17380,1244,1.11 [1.05-1.19],0.0006948686432602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRM,Receptor-type tyrosine-protein phosphatase mu,19803,1452,0.70 [0.58-0.85],0.0003031179659739
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRS,Receptor-type tyrosine-protein phosphatase S,20111,1473,0.64 [0.53-0.77],2.126439154525048e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVR,Poliovirus receptor,20026,1465,1.48 [1.31-1.66],5.6722116794343984e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,19997,1460,1.34 [1.23-1.47],1.0402221956619947e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASSF2,Ras association domain-containing protein 2,19413,1415,1.18 [1.10-1.27],7.825026913409959e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,17344,1237,1.47 [1.29-1.68],1.1581604534938051e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP2,Retinol-binding protein 2,19775,1444,1.21 [1.14-1.28],2.637650306433859e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP5,Retinol-binding protein 5,19775,1444,1.36 [1.26-1.47],5.772205359931748e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP7,Retinoid-binding protein 7,17296,1239,1.20 [1.10-1.31],2.844559313954946e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1A,Lithostathine-1-alpha,19749,1440,1.21 [1.11-1.32],7.355436654222046e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1B,Lithostathine-1-beta,20111,1473,1.16 [1.08-1.25],5.807920953978733e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,20111,1473,1.15 [1.08-1.23],3.045208753656844e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG4,Regenerating islet-derived protein 4,19897,1452,1.30 [1.20-1.42],7.048527991613264e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,19888,1463,1.45 [1.25-1.67],4.236484681227886e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REN,Renin,19876,1453,1.16 [1.11-1.22],9.184692134779851e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMA,Repulsive guidance molecule A,20026,1465,0.71 [0.61-0.82],3.5949630012722388e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE1,Ribonuclease pancreatic,17396,1246,1.83 [1.51-2.22],9.012171613549695e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE4,Ribonuclease 4,16817,1198,1.46 [1.23-1.74],1.5502964497478054e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE6,Ribonuclease K6,17276,1238,1.89 [1.67-2.13],1.1119153097725118e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASET2,Ribonuclease T2,20035,1463,1.50 [1.27-1.77],1.7403642272033117e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,16956,1214,1.55 [1.31-1.82],2.041599369850743e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO1,R-spondin-1,19686,1445,1.36 [1.19-1.55],6.942387196661585e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO3,R-spondin-3,20020,1460,1.31 [1.12-1.54],0.0006129693073367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A11,Protein S100-A11,19723,1443,1.28 [1.18-1.38],3.4039074345695794e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB2,Lysosome membrane protein 2,19320,1416,1.62 [1.43-1.83],2.8649489765670875e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCG2,Secretogranin-2,19916,1453,1.31 [1.15-1.50],8.087999640379531e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB1A1,Uteroglobin,19880,1452,0.78 [0.73-0.84],2.794826670936896e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A1,Secretoglobin family 3A member 1,17016,1209,1.54 [1.26-1.88],2.631448835610763e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,19922,1455,1.14 [1.09-1.20],2.7086455226330825e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCLY,Selenocysteine lyase,19954,1456,1.44 [1.31-1.57],1.2084707220865692e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCPEP1,Retinoid-inducible serine carboxypeptidase,16883,1210,1.24 [1.11-1.38],0.0001613559538747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEL1L,Protein sel-1 homolog 1,16956,1214,1.31 [1.12-1.52],0.0004819743881126
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELENOP,Selenoprotein P,17415,1251,0.66 [0.51-0.83],0.0006079616127828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN8,Septin-8,17324,1238,1.50 [1.30-1.73],4.03486515701572e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA1,Alpha-1-antitrypsin,17072,1232,6.90 [3.29-14.47],3.2179253492287e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,17344,1246,2.56 [1.82-3.59],5.3661890549726486e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA6,Corticosteroid-binding globulin,17415,1251,1.91 [1.33-2.74],0.0005020621054666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB8,Serpin B8,20057,1466,1.21 [1.13-1.29],2.034431984019489e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPIND1,Heparin cofactor 2,17384,1249,1.62 [1.32-1.98],3.203773174985468e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE1,Plasminogen activator inhibitor 1,20111,1473,1.14 [1.06-1.22],0.0002815707025203
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPING1,Plasma protease C1 inhibitor,17384,1249,2.17 [1.60-2.95],6.594916388875613e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP1,Secreted frizzled-related protein 1,19625,1438,1.20 [1.08-1.34],0.0006340352548657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP4,Secreted frizzled-related protein 4,17016,1209,0.72 [0.62-0.83],6.896990092841181e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA1,Pulmonary surfactant-associated protein A1,19413,1415,1.15 [1.06-1.24],0.0004069546726398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,19413,1415,1.28 [1.18-1.39],1.0590823122094259e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPD,Pulmonary surfactant-associated protein D,19876,1453,1.14 [1.07-1.22],0.0001335941762092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHISA5,Protein shisa-5,17385,1242,1.88 [1.59-2.24],4.641778368025015e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIAE,Sialate O-acetylesterase,19922,1460,1.20 [1.08-1.32],0.0004127085050464
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC1,Sialoadhesin,19957,1459,1.27 [1.14-1.41],2.1375266031938165e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,19827,1454,1.29 [1.13-1.47],0.0001611834532877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,19876,1453,1.67 [1.42-1.96],9.568881584677464e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIT1,Signaling threshold-regulating transmembrane adapter 1,19474,1407,1.21 [1.12-1.32],3.2309040996873926e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF8,SLAM family member 8,19413,1415,1.16 [1.06-1.27],0.0008745419384542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC39A14,Zinc transporter ZIP14,19427,1432,1.29 [1.14-1.45],3.079577422704327e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,16871,1216,0.74 [0.62-0.87],0.0004189941634373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,20020,1460,0.70 [0.63-0.79],2.6725317689693196e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMNDC1,Survival of motor neuron-related-splicing factor 30,17296,1239,1.21 [1.12-1.30],3.6753113330112057e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,19931,1458,1.47 [1.34-1.60],1.2038885096006518e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,19929,1457,1.22 [1.13-1.31],5.86691665722194e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNRPB2,U2 small nuclear ribonucleoprotein B'',17349,1240,1.23 [1.12-1.35],9.893610765156083e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",19888,1463,1.41 [1.27-1.57],3.6638490728864783e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,19413,1415,1.24 [1.09-1.41],0.0008682663509988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,19888,1463,1.48 [1.34-1.62],3.3093427989891473e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,19827,1454,1.18 [1.10-1.26],1.8218111477799888e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,19828,1456,1.67 [1.40-1.99],9.718633302793073e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON1,Spondin-1,19897,1452,1.42 [1.24-1.62],2.2849450743300909e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON2,Spondin-2,19781,1445,1.65 [1.45-1.87],7.510948366936734e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,19839,1450,0.85 [0.82-0.89],1.7780390513317922e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",20111,1473,1.63 [1.45-1.84],8.35017835549939e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC1,Stanniocalcin-1,20026,1465,1.23 [1.11-1.35],5.952375113214508e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT2A1,Bile salt sulfotransferase,19827,1454,1.31 [1.23-1.41],1.0231476897151392e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD2,Sushi domain-containing protein 2,19888,1463,1.44 [1.24-1.69],2.772374792088944e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD5,Sushi domain-containing protein 5,16927,1203,0.69 [0.59-0.80],2.027380458335291e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,19775,1444,1.26 [1.12-1.42],0.000148068844325
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAX1BP1,Tax1-binding protein 1,17349,1240,1.15 [1.06-1.25],0.0009983084611848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN2,Transcobalamin-2,20088,1470,1.30 [1.13-1.50],0.0002870693563977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCOF1,Treacle protein,17380,1244,1.37 [1.18-1.60],4.436370150891593e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCTN3,Tectonic-3,17380,1244,1.70 [1.42-2.04],8.742881587654713e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF1,Trefoil factor 1,19788,1459,1.20 [1.14-1.26],9.4442505366703e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF2,Trefoil factor 2,19922,1455,1.47 [1.37-1.58],8.558368063023105e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF3,Trefoil factor 3,19854,1444,1.53 [1.43-1.64],2.1280519767312528e-33
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,19901,1459,1.36 [1.27-1.46],6.593625695451112e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFA,Protransforming growth factor alpha,19827,1454,1.44 [1.32-1.57],2.289415720497743e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,20026,1466,1.28 [1.14-1.45],5.3818922097794136e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR2,TGF-beta receptor type-2,19953,1462,1.25 [1.11-1.42],0.000421134528409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS2,Thrombospondin-2,19888,1463,1.57 [1.42-1.75],2.263328104910527e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THOP1,Thimet oligopeptidase,19773,1445,1.29 [1.12-1.49],0.0003410735497571
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,19661,1430,1.70 [1.48-1.95],1.2387339195558612e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,19888,1463,1.52 [1.37-1.69],1.9084297529995988e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS5,Transmembrane protease serine 5,19601,1438,0.79 [0.70-0.90],0.000188577174455
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMSB10,Thymosin beta-10,19888,1463,1.12 [1.05-1.19],0.0004986151195952
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNF,Tumor necrosis factor,19463,1434,1.35 [1.23-1.48],9.719122145239043e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,17296,1239,1.23 [1.10-1.37],0.0001942996792046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,19686,1445,1.83 [1.62-2.06],3.5837650422285524e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,19686,1445,1.91 [1.86-1.96],0.0
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,20057,1466,1.28 [1.15-1.43],8.054916621970522e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,19870,1451,1.65 [1.42-1.92],5.635024365771641e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,19953,1462,1.68 [1.49-1.88],2.230877769570697e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,19897,1452,1.36 [1.18-1.57],1.921462675440237e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,19888,1463,1.70 [1.49-1.93],2.5566530817072296e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,19888,1463,1.53 [1.42-1.64],6.086613858927292e-33
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,19686,1445,1.39 [1.30-1.50],1.8004664293760984e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,19686,1445,1.20 [1.09-1.33],0.0002235484979254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF10,Tumor necrosis factor ligand superfamily member 10,20057,1466,0.74 [0.62-0.88],0.0008677657055527
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,19827,1454,0.78 [0.73-0.85],2.596140397886807e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,20057,1466,0.63 [0.53-0.74],2.5466449089091033e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,19957,1459,1.51 [1.28-1.78],9.281837676187464e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,20084,1473,1.71 [1.49-1.97],2.964408298600489e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNR,Tenascin-R,19686,1445,0.68 [0.61-0.75],2.3968682620106745e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPP1,Tripeptidyl-peptidase 1,19739,1442,1.61 [1.48-1.75],2.1298712602187847e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,19870,1451,1.47 [1.35-1.59],6.572487483713227e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN8,Tetraspanin-8,17296,1239,1.11 [1.05-1.17],0.0004721966077877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,19953,1462,1.37 [1.16-1.62],0.000221972308996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYMP,Thymidine phosphorylase,19744,1447,1.13 [1.05-1.21],0.0008069322778327
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ULBP2,UL16-binding protein 2,19686,1445,1.35 [1.20-1.51],2.416698784171793e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UMOD,Uromodulin,20051,1466,0.80 [0.73-0.86],2.7017819528633285e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP28,Ubiquitin carboxyl-terminal hydrolase 28,17349,1240,1.25 [1.10-1.43],0.000745640157141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,19484,1436,1.21 [1.13-1.30],3.0537050320147134e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFA,Vascular endothelial growth factor A,19994,1460,1.18 [1.09-1.27],2.958519113869433e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,17296,1230,1.26 [1.17-1.36],4.970277330950534e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,19862,1459,1.40 [1.27-1.56],8.511401471208587e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSNL1,Visinin-like protein 1,17349,1240,1.27 [1.11-1.45],0.00056169288461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,19987,1457,1.56 [1.40-1.74],3.4256256635163203e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWC2,Brorin,19621,1439,1.23 [1.10-1.38],0.0003310584067742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,19991,1459,1.20 [1.12-1.28],3.681202648049033e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,18903,1375,2.13 [1.95-2.32],7.56187471675331e-62
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",19615,1441,0.65 [0.58-0.72],1.2523873010017399e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YAP1,Transcriptional coactivator YAP1,17349,1240,1.44 [1.20-1.72],7.19345472360583e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,19484,1436,1.29 [1.19-1.41],6.682822503672063e-09
